Apollo Tyres Strong FY26 Performance with Final Dividend Declaration
Apollo Tyres has reported strong financial results for the quarter and year ended March 31, 2026. The company announced a final dividend of…
HUDCO Audited Financial Results and Dividend Announcement for FY 2025-26
HUDCO has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a significant annual net…
Akums Drugs & Pharmaceuticals Ltd. Strong FY26 Results and Dividend Announcement
Akums Drugs & Pharmaceuticals Ltd. has announced robust financial results for Q4 FY26 and the full fiscal year ended March 31, 2026. The…
Tata Motors Passenger Vehicles Limited Reports Q4 and Full-Year FY26 Financial Results
Tata Motors Passenger Vehicles Limited (TMPVL) announced its financial results for the quarter and year ended March 31, 2026. The company…
Sharda Cropchem Limited Submission of Annual Secretarial Compliance Report
Sharda Cropchem Limited has successfully submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The…
Apollo Tyres Strong FY26 Results with 600% Dividend Payout
Apollo Tyres Limited has announced its audited financial results for FY26, reporting a consolidated annual revenue of ₹284,706 million and a…
Dhanuka Agritech Limited Board Meeting to Consider Financials, ESOP, and Buyback
Dhanuka Agritech Limited has announced a Board of Directors meeting scheduled for May 19, 2026. The board will review the audited financial…
Orchid Pharma Monitoring Agency Report for Q4 Ended March 31, 2026
Orchid Pharma has released its monitoring agency report for the quarter ended March 31, 2026, detailing the utilization of proceeds from its…
Patel Engineering Robust Growth with FY26 Order Book at INR 1.51 Lakh Crore
Patel Engineering Limited has announced its financial performance for the quarter and fiscal year ended March 31, 2026. The company reported…
Biocon Q4 FY26 Results Reflect Strong Strategic Integration and Resilient Growth
Biocon Limited concluded FY26 with a resilient performance, marking a significant transition into a unified biopharma entity. The company…